General MedicationsORALGeneric
LORAZEPAM
LORAZEPAM
Standard Dose
0.5MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview LORAZEPAM is listed in Drugs@FDA under application 074648 (ANDA).
Marketing status: Discontinued Active ingredient LORAZEPAM Form and strength SOLUTION;ORAL - 0.5MG/5ML Sponsor ROXANE Submission history Latest submission status date: 1999-11-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview LORAZEPAM is listed in Drugs@FDA under application 074648 (ANDA). Marketing status: Discontinued Active ingredient LORAZEPAM Form and strength SOLUTION;ORAL - 0.5MG/5ML Sponsor ROXANE Submission history Latest submission status date: 1999-11-01 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.